| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |